Re: CFC - Publication of ACT Rules Format 1.1

+1


--

Len Beasley

918 630 5419
Colorado (MT)



From: Alastair Campbell <alastair.campbell@thisisgain.com>
Date: Tuesday, December 9, 2025 at 4:51 AM
To: WCAG list <w3c-wai-gl@w3.org>
Subject: [EXTERNAL] CFC - Publication of ACT Rules Format 1.1

**** External Email - Use Caution ****

________________________________
Call For Consensus — ends 16th December at midday Boston time.

Publication of the Accessibility Conformance Testing (ACT) Rules Format 1.1.

This update was introduced in the AG meeting on 2nd December:
https://www.w3.org/2025/12/02-ag-minutes.html#item02<https://www.w3.org/2025/12/02-ag-minutes.html#item02>

No comments have been made since then (issue 611<https://github.com/w3c/wcag-act/issues/611>).

There is a complete “diff” showing changes from version <https://services.w3.org/htmldiff?doc1=https%3A%2F%2Fwww.w3.org%2FTR%2Fact-rules-format-1.0%2F&doc2=https%3A%2F%2Fw3c.github.io%2Fwcag-act%2Fact-rules-format.html> 1.0 to 1.1<https://services.w3.org/htmldiff?doc1=https%3A%2F%2Fwww.w3.org%2FTR%2Fact-rules-format-1.0%2F&doc2=https%3A%2F%2Fw3c.github.io%2Fwcag-act%2Fact-rules-format.html>.

To support the CFC (publishing version 1.1) please reply to the group with a “+1”.

If you have concerns about this proposed consensus position that have not been discussed already and feel that those concerns result in you not being able to accept this decision, please reply with a “-1” and explanation before the CfC deadline.


Kind regards,



-Alastair



--



Alastair Campbell

Director of Accessibility

E: alastair.campbell@thisisgain.com<mailto:alastair.campbell@thisisgain.com>

 NOTICE TO RECIPIENT OF INFORMATION:
This e-mail may contain confidential or privileged information. If you think you have received this e-mail in error, please advise the sender by reply e-mail and then delete this e-mail immediately.  

This e-mail may also contain protected health information (PHI) with information about sensitive medical conditions, including, but not limited to, treatment for substance use disorders, behavioral health, HIV/AIDS, or pregnancy. This type of information may be protected by various federal and/or state laws which prohibit any further disclosure without the express written consent of the person to whom it pertains or as otherwise permitted by law. Any unauthorized further disclosure may be considered a violation of federal and/or state law. A general authorization for the release of medical or other information may NOT be sufficient consent for release of this type of information.

Thank you. Aetna